19-41331066-A-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PS1_ModeratePM2PP3_StrongPP5_Moderate
The NM_000660.7(TGFB1):āc.1159T>Cā(p.Cys387Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C387G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000660.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGFB1 | NM_000660.7 | c.1159T>C | p.Cys387Arg | missense_variant | 7/7 | ENST00000221930.6 | |
TGFB1 | XM_011527242.3 | c.1162T>C | p.Cys388Arg | missense_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGFB1 | ENST00000221930.6 | c.1159T>C | p.Cys387Arg | missense_variant | 7/7 | 1 | NM_000660.7 | P1 | |
TGFB1 | ENST00000600196.2 | c.1099T>C | p.Cys367Arg | missense_variant | 6/6 | 5 | |||
TGFB1 | ENST00000677934.1 | c.*12T>C | 3_prime_UTR_variant | 5/5 | |||||
TGFB1 | ENST00000598758.5 | n.302+1062T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1420780Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 703824
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inflammatory bowel disease, immunodeficiency, and encephalopathy Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 04, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Feb 27, 2019 | This variant is interpreted as a Likely pathogenic for Inflammatory bowel disease, immunodeficiency, and encephalopathy, autosomal recessive. The following ACMG Tag(s) were applied: PM2: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 : Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PM1 : Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation. The variant destroys disulfide bond between Cys322 and Cys387 (see UniProt P01137). PS3 : Well-established functional studies show a deleterious effect (PMID:29483653). - |
Encephalopathy;C4749850:Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | research | Klein lab, Ludwig-Maximilians-University | Jan 01, 2017 | Variant is associated with primary immunodeficiency, inflammatory bowel disease and encephalopathy. Variant was found in compound heterozygosity with another variant in TGFB1 (c.328C>T). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at